Close menu

March 28th, 2024 | 08:55 CET

Shares on a high: Up to 300% with Canopy Growth, Super Micro Computer, Aspermont

  • Technology
  • Digitization
  • Cannabis
Photo credits:

Is the German cannabis market on the verge of a tenfold increase? The head of Canopy Growth thinks so. The Company wants to profit from the boom. Canopy shares have already benefited and more than doubled. What are the Company's plans here in Germany? Super Micro Computer shares have already multiplied, but analysts remain bullish. Growth is expected to remain high. Aspermont offers a hot turnaround story. The B2B media company for the raw materials industry has freed itself from legacy burdens and now aims to grow more strongly again. Analysts see a high free cash flow and 300% share price potential!

time to read: 3 minutes | Author: Fabian Lorenz

Table of contents:

    Philip Schetter, CEO, Cantourage Group SE
    "[...] We are a producer and distributor of medicinal products and thus cover a crucial step in the value chain, especially within the cannabis industry. [...]" Philip Schetter, CEO, Cantourage Group SE

    Full interview


    Aspermont: GBC Research sees 300% opportunity

    Can Aspermont Limited shares multiply? Yes, say the analysts at GBC Research. Their price target is EUR 0.04. Aspermont shares are currently trading at around EUR 0.01. The optimism is quite understandable, as there is much to suggest that Aspermont's share price will rise: Attractive niche, strong growth, debt-free, and completed consolidation.

    2023 was a year of consolidation for the B2B media company for the raw materials industry. Nevertheless, Aspermont increased its turnover by 3% to AUD 19.20. Particularly pleasing: at AUD 11.1 million, over 70% of revenue is now recurring. At 57%, the gross margin is high and expected to increase to over 60% in the current year. Last year, a joint venture was terminated and written off. The net result fell accordingly from AUD -0.4 million to AUD -1.7 million in 2023. Other non-profitable products or events were also discontinued and new managers were brought on board. Aspermont now wants to focus on profitable and high-growth areas. According to GBC, this should already pay off in the current year. The analysts expect Aspermont to return to double-digit growth and increase revenue from AUD 21.56 million in the current year to over AUD 31 million by 2026. The EBITDA margin is expected to rise to 19.9% during this period. Free cash flow of AUD 4.30 million is expected as early as next year. Aspermont is currently valued at around AUD 40 million. The complete GBC study is available for download here.

    Canopy Growth: Share intoxicated by German fantasy

    Canopy Growth has shown in recent weeks that a share can quickly double due to turnaround fantasies. From April 1, 2024, cannabis will be officially recognized as a non-narcotic in Germany. The euphoria among investors is correspondingly high and shares in the sector have risen significantly in the past two weeks. Canopy Growth shares, for example, have more than doubled to EUR 6.89. However, an all-time low of EUR 2.80 was only reached at the beginning of March. Around three years ago, the share was still trading at over EUR 300. This puts the rise in the share price into perspective.

    In any case, Canopy sees itself in a good position to benefit from legalization in Germany. In a recent interview with Bloomberg, Canopy's CEO said that the German cannabis market could grow from the current EUR 500 million to EUR 2.5 billion in just a few years. In the medium term, he believes that the market in Germany could even reach a volume of EUR 5 billion. Canopy is active in Germany with the Storz & Bickel vaporizer brand and with Canopy Medical for medical cannabis products. The legalization of recreational cannabis and the expected growth of the medical cannabis market in Germany would offer exciting growth opportunities.

    Canopy manager Tara Rozalowsky comments: "The reclassification of cannabis as a non-narcotic is a critical step for patients and physicians, enabling them to better explore cannabis as a viable treatment option for a broader range of conditions. We are excited to continue serving the medical community with high-quality cannabis products that meet patients' needs, and we look forward to further expanding our already leading presence in the German medical cannabis market."

    Super Micro Computer: Further strong growth expected

    After the price fireworks that have driven Super Micro Computer's share price up by over 250% in the current year alone, it has been consolidating at a high level over the past two weeks. The AI boom is driving the Company's turnover and has even led the share into the S&P 500. Analysts are confident that the shares can do even better - but the air is getting thinner. JP Morgan has added the Super Micro Computer share to its coverage and recommends it as a "Buy". However, the target price of USD 1,150 is not far off the current level. The Company is one of the major beneficiaries of the rapidly increasing demand for data centers in the field of artificial intelligence.

    The analysts expect the market for "AI inferencing workloads" to multiply from USD 41 billion in 2023 to USD 283 billion by 2028, which should benefit Super Micro and enable the Company to grow by 43% per year over the next four to five years.

    Aspermont is a hot turnaround story. After last year's consolidation, the Company is poised for double-digit growth and rising margins. GBC's price target shows the direction it could take. In recent weeks, Canopy has demonstrated that bombed-out shares can quickly gain several hundred percent. However, doubts about the sustainability of the price increase are justified. Companies in the sector have not really been able to benefit operationally from the market openings in Canada and the US. Super Micro has excellent growth prospects. However, it must capitalize on them to justify its valuation of over USD 58 billion.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author

    Related comments:

    Commented by Juliane Zielonka on April 18th, 2024 | 07:00 CEST

    Volkswagen, Altech Advanced Materials, BYD - who can benefit from China's rise

    • Innovations
    • Technology
    • Electromobility
    • Batteries

    Chinese companies such as BYD benefit from state subsidies and domestic access to raw materials. BYD's subsidies have risen from EUR 220 million in just three years to EUR 2.1 billion. These sums are helping BYD dominate the Chinese electric vehicle market and increasingly penetrate the European market. Volkswagen cannot escape the pull of China either. As part of its "In China, for China" strategy, Volkswagen is expanding its cooperation network with Chinese partners. The aim is to reduce costs significantly in the development of EV technology. For companies like Altech Advanced Materials, close cooperation with Chinese market leaders such as BYD and Volkswagen offers the opportunity to commercialize innovative battery technologies that meet the needs of the changing market. One of these innovations, made in Germany by Altech Advanced Materials, increases the longevity of EV batteries by 30%. Here are the details.


    Commented by Juliane Zielonka on April 11th, 2024 | 07:45 CEST

    Innovation made in Europe: Singulus Technologies, Siemens Energy, BASF - which share offers the greatest potential?

    • renewableenergies
    • chemicals
    • Technology

    Companies in Europe, like Singulus Technologies, are leaders in the production of surface materials in future-oriented sectors such as photovoltaics, semiconductors, medical technology and cosmetics. This is reason enough to take a closer look at Europe as a location. The European Commission is determined to push ahead with CO₂ reduction with all its might and subsidize future energies. They would prefer to lock out Chinese companies that produce solar and wind turbines more cost-effectively than Siemens Energy. However, China is also an excellent place to do business. Chemical giant BASF strategically adheres to long-term contracts, in line with the Chinese strategist Sun Tzu. Which share offers the greatest potential for investors?


    Commented by André Will-Laudien on April 9th, 2024 | 07:00 CEST

    Big Tech in focus - get in or get out? 100% with Singulus, caution for Nvidia and Super Micro Computer!

    • bigtech
    • Technology
    • AI
    • chips

    The direction for the second quarter is still uncertain in the stock markets. Big Tech stocks have so far more than met investors' expectations, but they have not risen across the board for two weeks. This is also causing the NASDAQ 100 index to enter a consolidation phase, which delivered a significant downward swing just last Thursday. The global markets are still characterized by ample liquidity and the hope that the central banks will cut interest rates by the early summer. However, the upward movement has become very selective. Fueled by a flood of money for the "Magnificent Seven", other major markets, such as the Nikkei 225 and the DAX 40 index, also reached new highs. However, investors should now be on their guard, as a correction could be lurking after the upcoming dividend round in April. We delve a little deeper.